Search

Displaying results 8911 - 8920 of 9667 in total
  1. Drug

    RPI-78M

    go.drugbank.com/drugs/DB05740
    Experimental

    RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).

  2. Drug

    ARG201

    go.drugbank.com/drugs/DB06621
    Experimental

    This drug was investigated in the completed clinical trial NCT0000567 (Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma)

  3. Drug

    Tocofibrate

    go.drugbank.com/drugs/DB19752
    Experimental

    Tocofibrate has a monoisotopic molecular weight of 626.41 Da.

  4. Drug

    Nicofibrate

    go.drugbank.com/drugs/DB19916
    Experimental

    Nicofibrate has a monoisotopic molecular weight of 305.08 Da.

  5. Drug

    Dulofibrate

    go.drugbank.com/drugs/DB20032
    Experimental

    Dulofibrate has a monoisotopic molecular weight of 324.03 Da.

  6. Drug

    Pirifibrate

    go.drugbank.com/drugs/DB20620
    Experimental

    Pirifibrate has a monoisotopic molecular weight of 335.09 Da.

  7. Drug

    Salafibrate

    go.drugbank.com/drugs/DB20767
    Experimental

    Salafibrate has a monoisotopic molecular weight of 646.14 Da.

  8. Drug

    Elarofiban anhydrous

    go.drugbank.com/drugs/DB21212
    Experimental

    Elarofiban anhydrous has a monoisotopic molecular weight of 416.24 Da.

  9. Drug

    Atigliflozin

    go.drugbank.com/drugs/DB21394
    Investigational

    Atigliflozin has a monoisotopic molecular weight of 382.11 Da.

  10. Drug

    Lifibrate

    go.drugbank.com/drugs/DB21399
    Experimental

    Lifibrate has a monoisotopic molecular weight of 409.08 Da.